Log in or Sign up for Free to view tailored content for your specialty!
Respiratory Medicine News
Childhood vaccines prevented 1.1 million deaths in US over past 30 years
Routine childhood vaccinations prevented more than 1.1 million deaths among children born during the past 30 years in the United States, CDC researchers found.
WHO launches effort to develop mRNA vaccine against bird flu
WHO this week announced a project to speed development of a messenger RNA vaccine against highly pathogenic avian influenza in humans.
Log in or Sign up for Free to view tailored content for your specialty!
PAHO issues alert over spike in pertussis cases
The Pan American Health Organization issued an epidemiological alert in July regarding a significant rise in pertussis cases in the Americas and across the globe, according to a press release.
Optimizing flu protection in older adults: Enhanced vs. standard-dose vaccines
Influenza is responsible for significant mortality and hospitalization rates in the United States, ranging from 4,900 to 51,000 deaths and 100,000 to 710,000 hospitalizations annually between 2010 and 2023, according to the CDC.
Q&A: Risk for long COVID has declined, remains ‘substantial’
The risk for developing long COVID declined over the course of the pandemic but has remained significant, researchers reported.
CDC confirms new bird flu cases in Colorado poultry workers
The CDC said it has confirmed four new cases of highly pathogenic avian influenza in Colorado poultry workers and is aware of a fifth presumptive-positive case.
Study: SARS-CoV-2 reinfections have similar severity to initial infection
The severity of a SARS-CoV-2 reinfection is likely to be similar to the severity of a patient’s initial infection, researchers found.
Children absorb less secondhand nicotine through vapor vs. smoke
Children absorb significantly less nicotine when they are exposed to secondhand vapor from an e-cigarette compared with secondhand smoke, according to a study published in JAMA Network Open.
NIH-sponsored trial of nasal COVID-19 vaccine begins enrollment
A first-in-human trial of a nasal COVID-19 vaccine candidate began enrolling adults aged 18 to 64 years who have received at least three prior doses of a COVID-19 messenger RNA vaccine, according to the NIH.
More real-world evidence shows nirsevimab protects infants against RSV
The monoclonal antibody nirsevimab reduced the risk that infants would be hospitalized for respiratory syncytial virus-associated bronchiolitis, according to a study published Wednesday in The New England Journal of Medicine.
-
Headline News
‘We have a home’: Physician aims to create network of women allergists
November 14, 20245 min read -
Headline News
Diversified portfolios allow for ‘smoother ride’
November 14, 20243 min read -
Headline News
Predelivery concussion linked to increased risk for severe maternal mental illness
November 12, 20242 min read
-
Headline News
‘We have a home’: Physician aims to create network of women allergists
November 14, 20245 min read -
Headline News
Diversified portfolios allow for ‘smoother ride’
November 14, 20243 min read -
Headline News
Predelivery concussion linked to increased risk for severe maternal mental illness
November 12, 20242 min read